Clin2
NCT07178444Possibly a fitNot yet recruiting

Team-based program after heart attack to lower cholesterol

Acute Coronary Syndromes (ACS)Acute Coronary Syndromes

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study tests whether a team-based program (including diet, exercise, and medication management) helps people who have had a heart event lower their 'bad' cholesterol (LDL) more effectively than standard care. It may help reduce your risk of future heart problems.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
230 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are an adult who has been in the hospital for a heart attack or unstable angina (a type of chest pain).
  • You have not had serious complications from that heart event, such as severe heart failure or a blood clot in the heart.
  • You do not have memory problems or an active mental health condition that would make it hard to follow the program.
  • You do not have an active infection or an inflammatory condition, and you have no bone or joint problems that would stop you from doing physical activity.
  • You are not in another research study that aims to lower cholesterol, and you are not receiving state medical assistance or under legal guardianship.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07252388Not yet recruiting
Learning about cholesterol-lowering to prevent heart problems

This study tests an educational program to help people understand and lower their LDL ('bad') cholesterol after a heart-related event. It aims to improve awareness and encourage the use of cholesterol-lowering treatments.

Orbassano, TO
NCT06821711Not yet recruiting
Lowering cholesterol after heart stent procedure

This trial compares different LDL cholesterol targets to find the best level for people at very high risk after a heart stent procedure. It tests whether aiming for a lower cholesterol goal improves outcomes.

Xi'an, Shannxi
NCT07824323Recruiting· Phase 4
Early cholesterol treatment after a heart attack

This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.

Taipei, Taipei City
NCT06738758Recruiting
Early intensive cholesterol-lowering study for acute coronary syndrome

This study tests whether starting strong cholesterol-lowering treatment early in the hospital can improve outcomes for people with acute coronary syndrome (a serious heart condition like a heart attack or unstable angina). It may help if you have high LDL cholesterol.

Beijing, Beijing Municipality
NCT07508254Not yet recruiting· Phase 4
Comparing two vs three cholesterol-lowering drugs after a heart attack

This study compares two approaches to lowering 'bad' cholesterol (LDL-C) in people hospitalized with acute coronary syndrome (a heart attack or unstable angina). One approach uses two medications (a statin plus another pill), and the other uses three (adding an injectable medicine). The goal is to see if the triple therapy lowers cholesterol more effectively and helps prevent future heart problems.

Lahore, Punjab Province
NCT07799779Not yet recruiting· Phase 4
Early cholesterol treatment for heart attack patients

This study tests whether a newer cholesterol-lowering injection, given early after a heart attack, helps keep the plaque in your arteries stable and reduces future risk. It compares the new medicine added to your usual statin treatment.

Seongnam-si, Gyeonggi-do

Hear when a new Acute Coronary Syndromes (ACS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.